These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37391829)

  • 1. Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration.
    Mannino D; Scuderi SA; Casili G; Bova V; Cucinotta L; Lanza M; Filippone A; Esposito E; Paterniti I
    J Neuroinflammation; 2023 Jun; 20(1):155. PubMed ID: 37391829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration.
    Ardizzone A; Bova V; Casili G; Filippone A; Campolo M; Lanza M; Esposito E; Paterniti I
    J Neuroinflammation; 2022 May; 19(1):107. PubMed ID: 35526035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transcription Factor Nrf2 Mediates the Effects of
    Lanza M; Cucinotta L; Casili G; Filippone A; Basilotta R; Capra AP; Campolo M; Paterniti I; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
    J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
    Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model.
    Song MK; Lee JH; Kim J; Kim JH; Hwang S; Kim YS; Kim YJ
    Neurosci Lett; 2021 Jan; 740():135425. PubMed ID: 33075422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
    J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
    Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease.
    Kim YM; Choi SY; Hwang O; Lee JY
    Mol Neurobiol; 2022 Nov; 59(11):6956-6970. PubMed ID: 36057709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.
    Costa T; Fernandez-Villalba E; Izura V; Lucas-Ochoa AM; Menezes-Filho NJ; Santana RC; de Oliveira MD; Araújo FM; Estrada C; Silva V; Costa SL; Herrero MT
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):390-402. PubMed ID: 32564332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
    Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU
    Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
    Li Q; Shen C; Liu Z; Ma Y; Wang J; Dong H; Zhang X; Wang Z; Yu M; Ci L; Sun R; Shen R; Fei J; Huang F
    Cell Prolif; 2021 Aug; 54(8):e13094. PubMed ID: 34312932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
    Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
    FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade.
    Kuo HC; Lu CC; Shen CH; Tung SY; Hsieh MC; Lee KC; Lee LY; Chen CC; Teng CC; Huang WS; Chen TC; Lee KF
    J Transl Med; 2016 Mar; 14():78. PubMed ID: 26988860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.